PLUG-IN: Pembrolizumab Combined With Enfortumab Vedotin for Advanced Melanoma Patients
Clinical trial NCT06906822 · RECRUITING
Trial details
- NCT number
- NCT06906822
- Sponsor
- Grupo Español Multidisciplinar de Melanoma
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-10
- Primary completion
- 2027-06-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.